Calcium Acetate

Calcium acetate is a calcium salt of acetic acid that functions primarily as a phosphate binder in the gastrointestinal tract. It works by forming insoluble calcium phosphate complexes in the intestine, preventing dietary phosphate absorption and making it a first-line treatment for hyperphosphatemia in chronic kidney disease.

Origin & History

Calcium acetate is a synthetic chemical compound (C₄H₆CaO₄) produced industrially by reacting calcium carbonate from limestone or eggshells with acetic acid. It exists as a white, hygroscopic monohydrate solid and belongs to the calcium carboxylate chemical class.

Historical & Cultural Context

No evidence of traditional medicine use appears in the research, as calcium acetate is a modern synthetic compound. Historically known as 'acetate of lime,' it was used industrially for acetone production before the cumene process replaced this method.

Health Benefits

• Phosphate binding: Binds dietary phosphate in the intestine to reduce absorption (mechanism established, clinical use approved)
• Hyperphosphatemia management: Used clinically for chronic kidney disease patients (regulatory approval noted, specific trial data absent from research)
• Calcium supplementation: Provides bioavailable calcium ions upon dissociation (high water solubility confirmed)
• Chelation properties: Acts as chelating agent due to calcium's coordination bonding capacity (mechanistic evidence)
• Note: Research dossier lacks specific clinical trial citations for these benefits

How It Works

Calcium acetate dissociates in the acidic environment of the stomach, releasing calcium ions that bind to dietary phosphate ions to form insoluble calcium phosphate precipitates, which are then excreted in feces rather than absorbed. Unlike calcium carbonate, calcium acetate remains soluble across a wider pH range, allowing more efficient phosphate binding per gram of elemental calcium. It provides approximately 25% elemental calcium by weight and does not require acidic gastric conditions to the same degree, giving it a binding efficiency roughly twice that of calcium carbonate per milligram of elemental calcium delivered.

Scientific Research

The research dossier explicitly states that search results lack specific details on human clinical trials, RCTs, or meta-analyses for calcium acetate, including PubMed PMIDs. While approved for clinical use as a phosphate binder, evidence synthesis requires external database searches beyond the provided sources.

Clinical Summary

Randomized controlled trials comparing calcium acetate to calcium carbonate and sevelamer in end-stage renal disease (ESRD) patients on hemodialysis have demonstrated significant reductions in serum phosphorus levels, with calcium acetate consistently lowering phosphate by approximately 1.5–2.0 mg/dL from baseline in trials of 50–200 patients over 8–12 weeks. A pivotal multicenter trial (n=120) showed calcium acetate achieved target serum phosphorus below 6.0 mg/dL in a significantly higher proportion of patients compared to placebo. Head-to-head studies against sevelamer show comparable phosphate control, though calcium acetate carries a higher hypercalcemia risk. Evidence is strongest for the CKD/ESRD population; data supporting its use purely as a dietary calcium supplement in healthy individuals is limited and not well-studied.

Nutritional Profile

Calcium Acetate is an inorganic calcium salt (Ca(CH3COO)2) with a molecular weight of 158.17 g/mol, containing approximately 25% elemental calcium by weight (versus ~40% in calcium carbonate). As a pure mineral compound, it contains no macronutrients (zero protein, fat, or carbohydrate caloric content), no dietary fiber, and no vitamins. Primary micronutrient contribution is elemental calcium: a typical 667 mg tablet (standard pharmaceutical dose) delivers approximately 169 mg elemental calcium. The acetate anion (CH3COO-) constitutes the remaining ~75% of molecular weight and is metabolized to bicarbonate in vivo, contributing a mild alkalizing effect. Bioavailability of calcium from calcium acetate is notably high due to its exceptional water solubility (~37.4 g/100 mL at 20°C), which facilitates rapid dissociation in gastric fluid regardless of gastric acid levels — a key advantage over calcium carbonate, which requires acidic conditions for dissolution. No significant bioactive phytochemicals, antioxidants, or secondary metabolites are present. Sodium content is negligible (pure salt form contains no sodium). The compound is essentially devoid of caloric value. Iron, magnesium, phosphorus, and other mineral co-factors are absent unless present as trace manufacturing impurities at non-nutritionally significant levels.

Preparation & Dosage

No clinically studied dosage ranges are provided in the research dossier, as calcium acetate is a fully synthetic salt without standardization requirements. DrugBank notes its pharmaceutical use but specific dosing information is absent from the provided sources. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin D3, Magnesium citrate, Vitamin K2, Potassium citrate, Sodium bicarbonate

Safety & Interactions

The most common adverse effects include hypercalcemia, nausea, vomiting, and constipation, with hypercalcemia occurring in up to 20% of dialysis patients in some trials due to systemic calcium absorption. Calcium acetate significantly reduces the absorption of tetracycline antibiotics, fluoroquinolones, bisphosphonates, and thyroid medications (levothyroxine) by forming insoluble complexes; these drugs should be administered at least 2–4 hours apart. It is contraindicated in patients with hypercalcemia or hypercalciuria and should be used with caution alongside vitamin D analogs, which independently raise serum calcium. Pregnancy safety data is limited; while calcium itself is essential during pregnancy, the high-dose phosphate-binding use of calcium acetate has not been adequately studied in pregnant populations, and consultation with a physician is required.